- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 30-31st, 2007
Washington University will host a scientific symposium supported by the National Heart Lung and Blood Institute (NHLBI) and the National Cancer Institute (NCI) to review progress in the application of nanotechnology for the diagnosis, treatment and prevention of cardiovascular disease and cancer. A one and a half day intensive program to educate participants in the current science in nanotechnologies. Oral and poster presentations will be made leading experts, local university faculty, and students.
This symposium is designed to raise awareness and increase the knowledge level of individuals for nanotechnology and to encourage dialogue between the nanotechnology and clinical scientists.
This workshop will highlight the current state-of-the-art on the field of study to develop nanoscale materials to impact the life sciences.
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is an international leader in cancer treatment, research, prevention, education and community outreach. It is the only cancer center in Missouri and within a 240-mile radius of St. Louis to hold the prestigious Comprehensive Cancer Center designation from the National Cancer Institute and membership in the National Comprehensive Cancer Network. Parent institutions Barnes-Jewish Hospital and Washington University School of Medicine also are nationally recognized, with U.S. News & World Report magazine consistently ranking the hospital in the top 10 and the medical school in the top five.
For more information, please click here
(314) 454-8759 Fax: (314) 454-5265
Copyright © SCCNEIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016